Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
17.12.25
/
50%
€5.85
Target price
17.12.26
-
Performance (%)
1.37%
Price
22:25
€5.93
Summary
This prediction is currently active. With a performance of 1.37%, the BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals is trending in the right direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -1.358% | -1.358% |
| iShares Core DAX® | 3.593% | 6.427% |
| iShares Nasdaq 100 | 5.810% | 6.381% |
| iShares Nikkei 225® | 4.075% | 9.307% |
| iShares S&P 500 | 4.142% | 4.938% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
66.57%
22:25
22:25
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25

